Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).
- Messroghli DR Department of Internal Medicine and Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany. dmessroghli@dhzb.de.
- Moon JC University College London and Barts Heart Centre, London, UK.
- Ferreira VM Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
- Grosse-Wortmann L Division of Cardiology in the Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
- He T Cardiovascular Science Research Centre, St George's, University of London, London, UK.
- Kellman P National Institutes of Health, Bethesda, MD, USA.
- Mascherbauer J Department of Internal Medicine II, Division of Cardiology, Vienna, Austria.
- Nezafat R Department of Medicine (Cardiovascular Division), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA.
- Salerno M Departments of Medicine Cardiology Division, Radiology and Medical Imaging, and Biomedical Engineering, University of Virginia Health System, Charlottesville, VA, USA.
- Schelbert EB Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- Taylor AJ The Alfred Hospital, Baker Heart and Diabetes Institute, Melbourne, Australia.
- Thompson R Department of Biomedical Engineering, University of Alberta, Edmonton, Canada.
- Ugander M Department of Clinical Physiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- van Heeswijk RB Department of Radiology, Lausanne University Hospital (CHUV) and Lausanne University (UNIL), Lausanne, Switzerland.
- Friedrich MG Departments of Medicine and Diagnostic Radiology, McGill University, Montréal, Québec, Canada.
- 2017-10-11
Published in:
- Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. - 2017
Consensus
Europe
Heart
Heart Diseases
Humans
Image Processing, Computer-Assisted
Magnetic Resonance Imaging
Societies, Medical
English
Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR). Parametric mapping with CMR now permits the routine spatial visualization and quantification of changes in myocardial composition based on changes in T1, T2, and T2*(star) relaxation times and extracellular volume (ECV). These changes include specific disease pathways related to mainly intracellular disturbances of the cardiomyocyte (e.g., iron overload, or glycosphingolipid accumulation in Anderson-Fabry disease); extracellular disturbances in the myocardial interstitium (e.g., myocardial fibrosis or cardiac amyloidosis from accumulation of collagen or amyloid proteins, respectively); or both (myocardial edema with increased intracellular and/or extracellular water). Parametric mapping promises improvements in patient care through advances in quantitative diagnostics, inter- and intra-patient comparability, and relatedly improvements in treatment. There is a multitude of technical approaches and potential applications. This document provides a summary of the existing evidence for the clinical value of parametric mapping in the heart as of mid 2017, and gives recommendations for practical use in different clinical scenarios for scientists, clinicians, and CMR manufacturers.
- Language
-
- English
- Open access status
- gold
- Identifiers
-
- DOI 10.1186/s12968-017-0389-8
- PMID 28992817
- Persistent URL
- https://folia.unifr.ch/global/documents/265281
Statistics
Document views: 76
File downloads:
- Full-text: 0